Holen Sie sich die Stockscreener-App
4.82
0.62%
-0.03
Handel nachbörslich:
4.86
0.04
+0.83%
Schlusskurs vom Vortag:
$4.85
Offen:
$4.86
24-Stunden-Volumen:
1.81M
Relative Volume:
0.36
Marktkapitalisierung:
$1.68B
Einnahmen:
$62.90M
Nettoeinkommen (Verlust:
$-204.63M
KGV:
-8.0374
EPS:
-0.5997
Netto-Cashflow:
$-181.78M
1W Leistung:
+6.40%
1M Leistung:
+8.56%
6M Leistung:
+27.85%
1J Leistung:
+138.61%
1-Tages-Spanne:
$4.77
$4.93
1-Wochen-Bereich:
$4.375
$4.93
52-Wochen-Spanne:
$1.57
$9.75
Nuvation Bio Inc Stock (NUVB) Company Profile
Firmenname
Nuvation Bio Inc
Sektor
Branche
Telefon
332-208-6102
Adresse
1500 BROADWAY, NEW YORK
Compare NUVB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
4.82 | 1.69B | 62.90M | -204.63M | -181.78M | -0.5997 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-11-19 | Eingeleitet | B. Riley Securities | Buy |
| 2025-09-30 | Eingeleitet | Jefferies | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-03-08 | Eingeleitet | BTIG Research | Buy |
| 2021-03-08 | Eingeleitet | Cowen | Outperform |
| 2021-03-08 | Eingeleitet | Jefferies | Buy |
| 2021-03-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
Nuvation Bio Inc. (NUVB) turns bullish amid positive regulatory trajectory in Europe - MSN
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo - MSN
Ibtrozi Prospects Asserts Nuvation Bio Inc. (NUVB) as one of the Best Healthcare Penny Stocks - Insider Monkey
Nuvation Bio Executive Share Sale: CRO Kerry Wentworth Sells 200,000 SharesNews and Statistics - IndexBox
Market Fear: Is Nuvation Bio Inc stock undervalued right nowGap Down & Weekly Sector Rotation Insights - baoquankhu1.vn
Risk Hedge: Is Nuvation Bio Inc stock undervalued right nowWeekly Market Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) - Yahoo Finance
Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) - The Motley Fool
Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights - Insider Monkey
Nuvation Bio (NUVB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Aug Big Picture: Is Nuvation Bio Inc stock a hidden gemWeekly Stock Analysis & Daily Profit Maximizing Tips - baoquankhu1.vn
Nuvation Bio Inc. (NUVB): Billionaire David Abrams has a long-term bet on this stock - MSN
NUVB Stock Price, Quote & Chart | NUVATION BIO INC (NYSE:NUVB) - ChartMill
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Nuvation Bio (NUVB) - The Globe and Mail
RBC Capital Sticks to Their Buy Rating for Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio officer Wentworth sells $903k in shares By Investing.com - Investing.com Canada
Nuvation Bio officer Wentworth sells $903k in shares - Investing.com
Nuvation Bio stock rating reaffirmed at Buy by Truist Securities - Investing.com Australia
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $4.51 - Moomoo
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nuvation Bio Inc. (NUVB) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nuvation Bio Inc. (NUVB) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Nuvation Bio Inc. (NUVB) and Eisai get EMA validation for taletrectinib - MSN
JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Nuvation Bio Inc. (NUVB) Turns Bullish amid Positive Regulatory Trajectory in Europe - Yahoo Finance
[144] Nuvation Bio Inc. SEC Filing - Stock Titan
RBC Capital raises Nuvation Bio stock price target on glioma potential - Investing.com Canada
RBC Capital raises Nuvation Bio stock price target on glioma potential By Investing.com - in.investing.com
RBC Raises Price Target on Nuvation Bio to $20 From $13, Keeps Outperform, Speculative Risk - marketscreener.com
JPMorgan Chase & Co. Purchases 557,656 Shares of Nuvation Bio Inc. $NUVB - MarketBeat
Capricorn Fund Managers Ltd Makes New Investment in Nuvation Bio Inc. $NUVB - MarketBeat
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:NUVB | Press Release - Stockhouse
10 Best Multibagger Penny Stocks to Invest In - insidermonkey.com
Aug Reactions: Is Nuvation Bio Inc exposed to currency risks2026 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
Is EMA Validation Of Taletrectinib Expanding Nuvation Bio’s (NUVB) Targeted Lung Cancer Opportunity? - Sahm
Bronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc. (NUVB) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bullish analyst sentiment on Nuvation Bio (NUVB) amid early commercialization progress - MSN
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc. (NUVB) Shareholders to Inquire about Securities Investigation | NYSE:NUVB | Press Release - Stockhouse
Nuvation Bio Inc. (NUVB) amends protocol on safusidenib trials in astrocytoma - MSN
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact L - GuruFocus
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nuvation Bio Inc. (NUVB) And Encourages Investors to Connect - ACCESS Newswire
Nuvation Bio (NYSE:NUVB) Earns "Outperform" Rating from Wedbush - marketbeat.com
Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):